SEC
-
Telormedix secures further funding
Telormedix announced that it has raised 7.5 million CHF (US$8.1 million) from existing investors Aravis Venture and Proquest Investments.
SEC | 17 February 2012
-
Biomarkers Consortium of the FNIH selects ICON to support study evaluating variability in insulin secretory parameters
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced it has received a contract award from the Foundation for the National Institutes of Health (FNIH) to provide clinical support for the Biomarkers Consortium study entitled Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects.
SEC | 31 October 2011
-
ICON to support study evaluating variability in insulin secretory parameters
Selected by Biomarkers Consortium of the FNIH.
SEC | 21 October 2011
-
Surge in investment in electronic data systems by pharma sector
Ovum predicts strong demand in Asia Pacific for EDC solutions as the region continues to host an ever increasing share of multinational clinical trials.
SEC | 11 October 2011
-
Abbott named to Dow Jones Sustainability Indexes for seventh consecutive year
Receives recognition of leading corporate citizenship performance.
SEC | 09 September 2011
-
Roche named Dow Jones Sustainability Index leader in healthcare for third consecutive year
Reinforces commitment to creating long-term value for all stakeholders.
SEC | 09 September 2011
-
Abbott introduces vector-borne pathogen test to detect microorganisms carried by insects
Abbott's Ibis Biosciences has introduced a new molecular assay to detect a wide variety of vector-borne microorganisms, including those known to cause Lyme Disease, Rocky Mountain Spotted Fever, Babesiosis, Ehrlichiosis and Anaplasmosis. Vector-borne…
SEC | 10 August 2011
-
Pharmacovigilance: At the intersection of healthcare and life sciences
Pharmacovigilance and safety surveillance has evolved from yesterday’s focus on transactional activity and information fl ow to today’s awareness of the importance of risk management and proactive signal detection.
SEC | 01 July 2011
-
Pharmigene secures patents to warfarin dosage predictor
Pharmigene announced it has been granted patents in Europe, Japan, New Zealand, Mexico, Singapore, and Taiwan. The patents are related to methods used to predict dosage of the widely-prescribed anti-coagulant drug warfarin based on genetic variations…
SEC | 03 June 2011
-
Dimerix enters into second research program with Takeda Cambridge
Dimerix Bioscience Pty Ltd announced that it has entered into a second research program with Takeda Cambridge Limited. This new program is in addition to the continuing research program announced on 15 April 2010. Under the new agreement, Dimerix…
SEC | 14 April 2011
